Xiao-Jing Du

机构：Sun Yat-sen University, Shanghai East Hospital, Sun Yat-sen University Cancer Center · ORCID：0000-0001-5768-3576

发表论文 11 篇 · 总被引 971 次 · h-index 9

代表论文

• Comparative safety of immune checkpoint inhibitors in cancer: systematic review and network meta-analysis (2018 · BMJ · 被引 579)
• 10-Year Results of Therapeutic Ratio by Intensity-Modulated Radiotherapy Versus Two-Dimensional Radiotherapy in Patients with Nasopharyngeal Carcinoma (2018 · The Oncologist · 被引 97)
• Value of the prognostic nutritional index and weight loss in predicting metastasis and long-term mortality in nasopharyngeal carcinoma (2015 · Journal of Translational Medicine · 被引 92)
• Changes in Disease Failure Risk of Nasopharyngeal Carcinoma over Time: Analysis of 749 Patients with Long-Term Follow-Up (2017 · Journal of Cancer · 被引 58)
• Efficacy and safety of nimotuzumab in addition to radiotherapy and temozolomide for cerebral glioblastoma: a phase II multicenter clinical trial (2019 · Journal of Cancer · 被引 35)
• Circulating EBV DNA, Globulin and Nodal Size Predict Distant Metastasis after Intensity-Modulated Radiotherapy in Stage II Nasopharyngeal Carcinoma (2016 · Journal of Cancer · 被引 33)